Audrey Mailliez

11PUBLICATIONS
79CO-AUTHORS
Molecular targetsPsychosocial aspects of childbirth and perinatal mental healthCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 23, 2025
Combination of Olaparib, Durvalumab, and Fulvestrant in Patients with Advanced ER+/HER2- Breast Cancer and Selected Genomic Alterations: Results of the DOLAF Trial.

Séverine Guiu, Judith Balmaña, Pablo Lemercier

|Jul 09, 2025
Breastfeeding After Hormone Receptor-Positive Breast Cancer: Results From the POSITIVE Trial.

Fedro A Peccatori, Samuel M Niman, Ann H Partridge

|Jul 01, 2025
Posttreatment MRI to Predict Pathologic Complete Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy.

Toulsie Ramtohul, Derek Lollivier, Justine Spriet

|Apr 12, 2025
AMH decline during chemotherapy reflects breast cancer cell DNA damage response (DDR) proficiency: the ONCO AMH1 pilot study.

Christine Decanter, Audrey Dassonneville, Emmanuelle D'Orazio

|Jun 05, 2024
Therapeutic impact of 18F-FDG PET/CT for initial staging in patients with clinical stage I and IIA, HER2-positive, or triple-negative breast cancer.

Chloé François, Audrey Mailliez, Sebastian Chretien

|May 29, 2024
Fertility Preservation and Assisted Reproduction in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt Pregnancy.

Hatem A Azim, Samuel M Niman, Ann H Partridge

Pageof 2

Frequent Collaborators

2 joint publications

Anthony Goncalves

2 joint publications

Judith R Kroep

2 joint publications

Marco Colleoni

2 joint publications

Hatem A Azim